<?xml version="1.0" encoding="UTF-8"?>
<p>In some patients, tacrolimus reduction may be preferred over complete withdrawal (
 <xref rid="B67" ref-type="bibr">67</xref>, 
 <xref rid="B69" ref-type="bibr">69</xref>) because of direct alleged CNI antiviral properties or CNI anti-inflammatory action (
 <xref rid="B76" ref-type="bibr">76</xref>, 
 <xref rid="B77" ref-type="bibr">77</xref>). Pending the results of clinical studies, CNI withdrawal vs. reduction may be established on a case-by-case basis depending on the severity of pneumonia.
</p>
